Stocks
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | -9.34 | -50.3 | 34.6 | 11.1 | 1.98 | 1.32 | ||
| Changes by years, y/y, % | -9% | +438% | -169% | -68% | -82% | |||
Vanda Pharmaceuticals. Debt/EBITDA
Vanda Pharmaceuticals. Debt/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| Debt/EBITDA | 2.87 | 2.05 | 1.39 | 0.90 | 0.88 | 1.32 | ||
| Changes by years, y/y, % | -77% | -82% | -76% | -77% | -77% | |||
| Changes by quarters, q/q, % | -26% | -28% | -32% | -35% | -1% | |||
